참고문헌
- Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, et al (2012). miR-10b*, a master inhibitor of the cell cycle, is downregulated in human breast tumours. EMBO Mol Med, 4, 1214-29. https://doi.org/10.1002/emmm.201201483
-
Chen CF, He X, Arslan AD, et al (2011). Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase
$II\alpha$ and drug responsiveness. Mol Pharmacol, 79, 735-41. https://doi.org/10.1124/mol.110.069633 - Costa FF, Jared M, Bischof JM, et al (2011). Identification of MicroRNAs as potential prognostic markers in ependymoma. PLoS One, 6, 25114. https://doi.org/10.1371/journal.pone.0025114
-
Fils-Aime N, Dai M, Guo J, et al (2013). MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-
$\beta$ mediates the migration and actin dynamics of breast cancer cells. J Biol Chem, 288, 11807-23. https://doi.org/10.1074/jbc.M112.430934 - Haghighat S, Akbari M, Ghaffari S (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8. https://doi.org/10.7314/APJCP.2012.13.11.5525
- Harquail J, Benzina S, Robichaud GA (2012). MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark, 11, 269-80.
- Hu X, Guo J, Zheng L, et al (2013). The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Molec Cancer Res, 11, 240-50. https://doi.org/10.1158/1541-7786.MCR-12-0432
- Imam JS, Plyler JR, Bansal H, et al (2012). Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One, 7, 52397. https://doi.org/10.1371/journal.pone.0052397
- Kala R, Peek GW, Hardy TM, et al (2013). MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinform, 16, 6-13.
- Kim TH, Kim YK, Kwon Y, et al (2010). Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology, 57, 734-43. https://doi.org/10.1111/j.1365-2559.2010.03686.x
- Lages E, Ipas H, Guttin A, et al (2012). MicroRNAs: molecular features and role in cancer. Front Biosci, 17, 2508-40. https://doi.org/10.2741/4068
- Lee S, and Vasudevan S (2013). Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol, 768, 97-126. https://doi.org/10.1007/978-1-4614-5107-5_7
- Li S, Meng H, Zhou F, et al (2013). MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract, 209, 179-83. https://doi.org/10.1016/j.prp.2012.12.002
- Lodes MJ, Caraballo M, Suciu D, et al (2009). Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray. PLoS One, 4, 6229. https://doi.org/10.1371/journal.pone.0006229
- Parpart S, Wang XW (2013). microRNA Regulation and Its Consequences in Cancer. Curr Pathobiol Rep, 1, 71-9. https://doi.org/10.1007/s40139-012-0002-7
- Selcuklu SD, Donoghue MT, Rehmet K, et al (2012). MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem, 287, 29516-28. https://doi.org/10.1074/jbc.M111.335943
- Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. https://doi.org/10.3322/caac.20138
- Singh R, Mo YY (2013). Role of microRNAs in breast cancer. Cancer Biol Ther, 14, 201-12. https://doi.org/10.4161/cbt.23296
- Tang J, Ahmad A, Sarkar FH (2012). The role of MicroRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci, 13, 13414-37. https://doi.org/10.3390/ijms131013414
- Wang QY, Tang J, Zhou CX, et al (2012). The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility. Sheng Li Xue Bao, 64, 403-11.
- Yang H, Cho ME, Li TWH, et al (2013). MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest. 123, 285-298. https://doi.org/10.1172/JCI63861
- Yang L, Sun TT, Wang N (2012). The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008. Zhonghua Yu Fang Yi Xue Za Zhi, 46, 1009-14.
- Zhou J, Tian Y, Li J, et al (2013). miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. Biochem Biophys Res Commun, 433, 207-12. https://doi.org/10.1016/j.bbrc.2013.02.084
피인용 문헌
- Analysis of the microRNA expression profile of normal human dermal papilla cells treated with 5α-dihydrotestosterone vol.12, pp.1, 2015, https://doi.org/10.3892/mmr.2015.3478
- Role of MicroRNAs in the Warburg Effect and Mitochondrial Metabolism in Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7015
- Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs vol.31, pp.6, 2014, https://doi.org/10.1007/s10585-014-9664-3
- An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes vol.5, pp.1664-8021, 2014, https://doi.org/10.3389/fgene.2014.00246
- miR-485-5p inhibits bladder cancer metastasis by targeting HMGA2 vol.36, pp.4, 2015, https://doi.org/10.3892/ijmm.2015.2302
- UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis vol.37, pp.8, 2016, https://doi.org/10.1007/s13277-016-4917-1
- MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression vol.7, pp.3, 2016, https://doi.org/10.1038/cddis.2016.27
- Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma vol.12, pp.9, 2017, https://doi.org/10.1371/journal.pone.0184969
- MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4 vol.51, pp.5, 2017, https://doi.org/10.3892/ijo.2017.4122
- Developments in oligometastatic hormone-sensitive prostate cancer pp.1433-8726, 2019, https://doi.org/10.1007/s00345-018-2542-x
- The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3 vol.233, pp.9, 2018, https://doi.org/10.1002/jcp.26371